Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates

Background: Our previous studies showed the safe preventive and therapeutic effects of immunization using the nanoliposomal antiPCSK9 vaccine called “Liposomal Immunogenic Fused PCSK9-Tetanus plus Alum adjuvant” (L-IFPTA), in mouse models of atherosclerosis. Here we aimed to ascertain the immunogeni...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Vaccines (Basel)
Main Authors: Momtazi-Borojeni, Amir Abbas, Jaafari, Mahmoud R., Banach, Maciej, Gorabi, Armita Mahdavi, Sahraei, Hedayat, Sahebkar, Amirhossein
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8309966/
https://ncbi.nlm.nih.gov/pubmed/34358164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9070749
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki